Xolair 75 mg solution for injection in pre-filled syringe

Prospective, open-label study to analyze the efficacy and safety of low-dose oral immunotherapy in children with severe IgE-mediated cow's milk allergy treated with omalizumab. ILO study.

SHORTEN - Impact of omalizumab withdrawal after a 3 year duration treatment in well controlled severe allergic asthma : a multicentric randomized controlled trial

Therapheutic optimization of omalizumab in allergic severe asthma patients by dose and frequency of administration adjustment